Report Detail

“Mibg Scan Market” 2018-2026 report is a professional study on the current state of the market that focuses on the major drivers, challenges, opportunities for the leading players. The research report also offers a granular analysis of various definitions, and classification of the industry, applications of the industry, regional breakdown, opportunities, challenges, and chain structure.

About Mibg Scan Market

MIBG scan, also called as MIBG scintigraphy or MIBG scintiscan, is a type of nuclear medicine procedure used to locate known or suspected neuroendocrine and neuroectodermal tumors. This scanning procedure injects a radioactive material called iodine-123-meta-iodobenzylguanidine (MIGB), the most sensitive and specific radioactive tracer used for the diagnosis and monitoring of neuroectodermal & neuroendocrine tumors. According to the American Cancer Society, neuroblastoma is the most prevalent cancer in infants of age less than one year. In addition, every year approximately 800 new cases of neuroblastoma arise in the United States, which is boosting the growth of global MIBG scan market. MIGB scan cannot be performed after the consumption of certain drugs such as opioids, amiodarone, reserpine, tricyclic antidepressants, sympathicomimetics, guanethidine, calcium channel blockers, & ACE inhibitors and requires prior discontinuation of these drugs before the administration of MIGB.

In the current scenario, physicians are witnessing hurdles in the adoption of MIBG scan, especially in the paediatric neuroblastoma cases as it becomes difficult to extract the information from the low definition images produced with poor contours, resolution and contrast.

Market Summary:

The Mibg Scan market is a comprehensive report which offers a meticulous overview of the market share, size, trends, demand, product analysis, application analysis, regional outlook, competitive strategies, forecasts, and strategies impacting the Mibg Scan Industry. The report includes a detailed analysis of the market competitive landscape, with the help of detailed business profiles, SWOT analysis, project feasibility analysis, and several other details about the key companies operating in the market.

The study on the worldwide Mibg Scan market strives to offer substantial and profound insights into the current market scenario and the developing growth dynamics. Moreover, the report also provides the market players along with the new contenders a complete view of the market landscape. The inclusive research will enable the well-established as well as the entry-level players to establish their business strategies and accomplish their short-term and long-term goals.

Scope and Segmentation of the Report

The segment analysis is one of the significant sections of this report. Our expert analyst has categorized the market into product type, application/end-user, and geography. All the segments are analyzed based on their market share, growth rate, and growth potential. In the geographical classification, the report highlights the regional markets having high growth potential. This thorough evaluation of the segments would help the players to focus on revenue-generating areas of the Mibg Scan market.

Based on Type

Product 1
Product 2

Based on Application

Pheochromocytoma
Ganglioneuroma
Ganglioneuroblastoma
Paraganglioma
Carcinoid tumor
Neuroblastoma
Others

Regional Analysis

Our analysts are experts in covering all types of geographical markets from developing to mature ones. You can expect a comprehensive research analysis of key regional and country-level markets such as Europe, North America, South America, Asia-Pacific, and the Middle East & Africa. With accurate statistical patterns and regional classification, our domain experts provide you one of the most detailed and easily understandable regional analyses of the Mibg Scan market.

Competitive Landscape:

The research report also studied the key players operating in the Mibg Scan market. It has evaluated and explained the research & development stages of these companies, their financial performances, and their expansion plans for the coming years. Moreover, the research report also includes the list of planned initiatives that clearly explain the accomplishments of the companies in the recent past.

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products, etc.):

Capital Health
GE Healthcare
Jubilant Pharma. LLC
Siemens Healthcare

Research Methodology

The research methodology of the market is based on both primary as well as secondary research data sources. It compels different factors affecting the Mibg Scan industry such as historical data and market trends, different policies of the government, market environment, market risk factors, market restraints, technological advancements, forthcoming innovations, and obstacles in the industry.

The content of the study subjects includes a total of 8 chapters:

Chapter 1, describe the Mibg Scan market report’s – executive summary, market definition, and market scope. Moreover, the report helps in picking up the crucial information about the said market.

Chapter 2, defines the Research Methodology including primary research, assumptions & exclusions, and secondary data sources. The report follows the simultaneous top-down and bottom approach to provide you the accurate market sizing.

Chapter 3, explains the report segmentation & scope, key market trends (drivers, restraints, and opportunities), along with Porter’s five forces analysis and market share analysis

Chapter 4: It helps in understanding the key product segments and their future of the Mibg Scan Market. It provides strategic recommendations in key business segments based on the market estimations.

Chapters 5, and 6 to segment the sales by type and application/end-user, with sales market share and growth rate by type, application/end-user, from 2018 to 2016. Our team of Analysts and experts dedicatedly put their effort to provide you the best possible and accurate segmentation data and analysis.

Chapter 7, describes the regional segmentation based on the country level for the forecast period 2018 – 2026. The research report not only provide the market data of the five geographies but also provide the qualitative as well we qualitative information on country level bifurcation.

Chapter 8, to profile the top manufacturers of Mibg Scan, with price, sales, revenue and market share of Mibg Scan in 2016, 2017, and 2018. Players are expected to sign acquisition and collaboration deals to expand their products and services portfolio. Such strategic agreements could help them to improve their client base in other countries and gain a competitive advantage


CHAPTER 1. INTRODUCTION

  • 1.1. RESEARCH METHODOLOGY
    • 1.1.1. ERC DESK RESEARCH
    • 1.1.2. ERC DATA SYNTHESIS
    • 1.1.3. DATA VALIDATION AND MARKET FEEDBACK
    • 1.1.4. ERC DATA SOURCES

CHAPTER 2. MIBG SCAN MARKET OVERVIEW

  • 2.1. MIBG SCAN MARKET INTRODUCTION
  • 2.2. GLOBAL MIBG SCAN MARKET REVENUE AND GROWTH RATE, 2017-2025
    • 2.2.1. GLOBAL MIBG SCAN MARKET REVENUE (MILLION USD) AND GROWTH RATE (%), (2017-2025)

CHAPTER 3. GLOBAL MIBG SCAN MARKET BY SERVICE PROVIDER, 2017-2025

  • 3.1. HOSPITALS
  • 3.2. PRIVATE RADIOLOGY CLINICS
  • 3.3. GLOBAL MIBG SCAN MARKET REVENUE BY SERVICE PROVIDER, 2017-2025
    • 3.3.1. GLOBAL MIBG SCAN MARKET REVENUE (MILLION USD) AND SHARE (%) BY SERVICE PROVIDER, 2017-2025
    • 3.3.2. HOSPITALS MARKET REVENUE AND GROWTH RATE, 2017-2025
    • 3.3.3. PRIVATE RADIOLOGY CLINICS MARKET REVENUE AND GROWTH RATE, 2017-2025

CHAPTER 4. GLOBAL MIBG SCAN MARKET BY APPLICATION, 2017-2025

  • 4.1. PHEOCHROMOCYTOMA
  • 4.2. GANGLIONEUROMA
  • 4.3. GANGLIONEUROBLASTOMA
  • 4.4. GLOBAL MIBG SCAN MARKET REVENUE BY APPLICATION, 2017-2025
    • 4.4.1. GLOBAL MIBG SCAN MARKET REVENUE (MILLION USD) AND SHARE (%) BY APPLICATION, 2017-2025
    • 4.4.2. PHEOCHROMOCYTOMA MARKET REVENUE AND GROWTH RATE, 2017-2025
    • 4.4.3. GANGLIONEUROMA MARKET REVENUE AND GROWTH RATE, 2017-2025
    • 4.4.4. GANGLIONEUROBLASTOMA MARKET REVENUE AND GROWTH RATE, 2017-2025

Note: Similar information coverage has been provided for other application segment.

    CHAPTER 5. GLOBAL MIBG SCAN MARKET BY REGION, 2017-2025

    • 5.1. NORTH AMERICA
      • 5.1.1. U.S.
      • 5.1.2. CANADA
      • 5.1.3. MEXICO
    • 5.2. EUROPE
      • 5.2.1. U.K.
      • 5.2.2. FRANCE
      • 5.2.3. GERMANY
      • 5.2.4. ITALY
      • 5.2.5. SPAIN
      • 5.2.6. REST OF EUROPE
    • 5.3. ASIA PACIFIC
      • 5.3.1. CHINA
      • 5.3.2. JAPAN
      • 5.3.3. INDIA
      • 5.3.4. KOREA
      • 5.3.5. REST OF APAC
    • 5.4. SOUTH AMERICA
      • 5.4.1. BRAZIL
      • 5.4.2. REST OF SOUTH AMERICA
    • 5.5. REST OF THE WORLD
      • 5.5.1. MIDDLE EAST
      • 5.5.2. AFRICA
    • 5.6. GLOBAL MIBG SCAN MARKET REVENUE BY REGION, 2017-2025
      • 5.6.1. GLOBAL MIBG SCAN MARKET REVENUE (MILLION USD) AND SHARE (%) BY REGION, 2017-2025
      • 5.6.2. NORTH AMERICA MARKET REVENUE AND GROWTH RATE, 2017-2025
      • 5.6.3. EUROPE MARKET REVENUE AND GROWTH RATE, 2017-2025
      • 5.6.4. ASIA PACIFIC MARKET REVENUE AND GROWTH RATE, 2017-2025
      • 5.6.5. SOUTH AMERICA MARKET REVENUE AND GROWTH RATE, 2017-2025
      • 5.6.6. REST OF THE WORLD MARKET REVENUE AND GROWTH RATE, 2017-2025

    CHAPTER 6. MARKET DETERMINANTS

    • 6.1. MARKET DRIVERS
    • 6.2. MARKET RESTRAINTS
    • 6.3. MARKET OPPORTUNITIES
    • 6.4. MARKET DETERMINANTS RADAR CHART

    CHAPTER 7. GLOBAL MIBG SCAN MARKET COMPETITION BY SERVICE PROVIDERS

    • 7.1. GLOBAL MIBG SCAN REVENUE AND SHARE BY SERVICE PROVIDERS (2017-2025)
      • 7.1.1. GLOBAL MIBG SCAN REVENUE (MILLION USD) AND SHARE (%) BY SERVICE PROVIDERS (2017-2025)
    • 7.2. MIBG SCAN MARKET COMPETITIVE SITUATION AND TRENDS
      • 7.2.1. MIBG SCAN MARKET SHARE (%) OF TOP 3 SERVICE PROVIDERS
      • 7.2.2. MIBG SCAN MARKET SHARE (%) OF TOP 5 SERVICE PROVIDERS

    CHAPTER 8. COMPANY PROFILES

    • 8.1. CAPITAL HEALTH
      • 8.1.1. BUSINESS OVERVIEW
      • 8.1.2. COMPANY BASIC INFORMATION
      • 8.1.3. MIBG SCAN PRODUCT DETAILS
      • 8.1.4. CAPITAL HEALTH MIBG SCAN REVENUE AND GROSS MARGIN
    • 8.2. GE HEALTHCARE
      • 8.2.1. BUSINESS OVERVIEW
      • 8.2.2. COMPANY BASIC INFORMATION
      • 8.2.3. MIBG SCAN PRODUCT DETAILS
      • 8.2.4. GE HEALTHCARE MIBG SCAN REVENUE AND GROSS MARGIN
    • 8.3. JUBILANT PHARMA. LLC
      • 8.3.1. BUSINESS OVERVIEW
      • 8.3.2. COMPANY BASIC INFORMATION
      • 8.3.3. MIBG SCAN PRODUCT DETAILS
      • 8.3.4. JUBILANT PHARMA. LLC MIBG SCAN REVENUE AND GROSS MARGIN
    • 8.4. SIEMENS HEALTHCARE
      • 8.4.1. BUSINESS OVERVIEW
      • 8.4.2. COMPANY BASIC INFORMATION
      • 8.4.3. MIBG SCAN PRODUCT DETAILS
      • 8.4.4. SIEMENS HEALTHCARE MIBG SCAN REVENUE AND GROSS MARGIN

    CHAPTER 9. MIBG SCAN MARKET VALUE CHAIN ANALYSIS

    • 9.1. MIBG SCAN INDUSTRIAL CHAIN ANALYSIS
    • 9.2. CONSUMER ANALYSIS
      • 9.2.1. CONSUMER 1
      • 9.2.2. CONSUMER 2
      • 9.2.3. CONSUMER 3

    Summary:
    Get latest Market Research Reports on MIBG Scan . Industry analysis & Market Report on MIBG Scan is a syndicated market report, published as MIBG Scan Market By Service provider (Hospitals, Private radiology clinics), By Application (Pheochromocytoma, Ganglioneuroma, Ganglioneuroblastoma, Paraganglioma, Carcinoid tumor, Neuroblastoma), Industry Trends, Estimation & Forecast, 2017 - 2025. It is complete Research Study and Industry Analysis of MIBG Scan market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,700.00
    $5,600.00
    3,708.30
    4,418.40
    4,324.00
    5,152.00
    729,299.00
    868,952.00
    392,450.00
    467,600.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report